PAR-27-010: National Produce Safety Partnership Program
Open
Food and Drug Administration is offering grants of up to $12.0 million to the applicants described in the notice. It expects to make about 56 awards worth $34.0 million in total. Applications are accepted on a rolling basis or until a date given in the notice.
From the official notice on Grants.gov, last changed November 4, 2026. Checked November 7, 2026.
- Award ceiling$12.0 million
- Total funding$34.0 million
- Expected awards56
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | November 4, 2026 |
|---|
Who can apply
This opportunity is open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
This funding opportunity is available only to state and territory government agencies with actual or potential regulatory oversight and responsibility over their respective jurisdiction's farms, produce commodities, and activities covered under FDA's Produce Safety Rule (21 CFR Part 112).
Is this a realistic fit?
- Past Food and Drug Administration Research awards averaged $1.3 million; this notice allows up to $12.0 million per award.
- Most of the program's money (35% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
This funding opportunity aims to improve the safety of fresh produce and prevent produce-related illnesses.
Who has won Food and Drug Administration Research grants before
From fiscal 2021 to 2025, Food and Drug Administration Research (93.103) awarded $1.2 billion across 940 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Critical Path Institute | Arizona | 13 | $94.0 million |
| National Environmental Health Association | Colorado | 9 | $55.4 million |
| Association of Food & Drug Officials | Pennsylvania | 14 | $50.3 million |
| The Medical Device Innovation Consortium | Virginia | 1 | $48.6 million |
| Duke University | North Carolina | 11 | $35.6 million |
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Stephanie Bogan, Grantor, Danielle.Head@fda.hhs.gov, 3018276802.
Questions people ask
Is PAR-27-010 still open?
Yes. Rolling or no fixed deadline.
Who can apply for National Produce Safety Partnership Program?
Food and Drug Administration accepts applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for National Produce Safety Partnership Program?
Rolling or no fixed deadline. Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
Awards of up to $12.0 million each. About $34.0 million in total across about 56 awards.
Who has won Food and Drug Administration Research grants before?
The largest recipients over five fiscal years were The Critical Path Institute, National Environmental Health Association, Association of Food & Drug Officials. The program made 940 awards worth $1.2 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)